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Pulmonary arteriovenous shunting is a serious 
complication of endstage liver disease(ESLD) and 
presents with a chronic hypoxic syndrome. Severe hypoxia 
has been considered a contraindicaton to orthotopic 
liver transplantation(OLTx). Four pediatric patients 
with ESLD and severe pulmonary arteriovenous shunting 
underwent OLTx. Immunosuppression was with Cyclosporin 
A in one patient and with FK506 in three patients. 
Hypoxia was reversed by successful OLTx in all patients. 
Case report 
[Patient 11 
See patient profile in Table 1) 
This 16 year old boy with Biliary 
Atresia received a Kasai procedure at the age 2 months 
and mesocaval shunt at age 15 years. He presented to 
us with worsening liver function and hypoxia. He was 
extremely fatigued, had deteriorating performance 
status, and was unable to attend school regularly. 
physical examination revealed remarkable central 
cyanosis and digital clubbing. He was apathetic and 
demonstrated a low level of reactivity to external 
stimuli. He also presented with polycytemia( hemoglobin 
of 16.6 g/dl and hematocrit of 47%). His liver function 
tests are shown in Table2. Arterial blood gas 
measurement demonstrated severe hypoxia with a pao 2 
of 56 mmHg. His pulmonary function test (Table 3) showed 
mild dysfunction which did not correlate with the 
severity of his hypoxia. 
He underwent OLTx on May 14, 1989 at age 16 
years. Intraoperatively the mesocaval shunt was found 
to be functional. The patient's native portal vein 
was hypoplastic down to the confluence of the splenic 
and superior mesenteric veins. A cadaveric vein graft 
was interposed, and the mesocaval shunt was ligated. 
The OLTx was otherwise unremarkable. Postoperative 
immunosuppression was with Cyclosporin A 150 mg twice 
a day, azathioprine 100 mg/day, and 20 mg of 
methylprednisolone started at 200 mg/day and then 
rapidly tapered to 20 mg/day over a ** period. He was 
extubated on the first postoperative day (POD#1). The 
patient's postoperative course was uneventful with 
the exception of one episode of acute cellular rejection 
which was treated with OKT3. He required supplemental 
oxygen for 10 days to keep Sa0 2 greater than 90%. His 
oxygenation improved gradually showing a pa02 of 88 
mmHg on room air and improved school performance 4 
months after OLTx. 
[Patient 2] This 7 year old girl with biliary atresia 
received a Kasai procedure at the age of 2 months. 
She was referred to our center because of worsening 
hypoxia which presented 6 months prior to admission. 
She had several episodes of viral upper respiratory 
tract infections, and progressively worsening 
oxygenation. The pao2 on room air was 38 mmHg, she 
exhibited cyanosis, mild polycytemia ( hematocrit of 
40.4% and hemoglobin of 14.1 g/dl), but no digital 
clubbing. Pulmonary function test was not performed. 
Her liver function tests are shown in Table2. 
She underwent uneventful OLTx on May 30, 1990. 
She was extubated on POD #1, however, she required 
reintubation for atelectases and hypoxia on POD #2. 
Immunosuppression was with FK506(O.15mg/kg/day 
intravenous for the first 5 days, then 0.3 mg/kg/day 
orally), and low dose steroids (methylprednisolone 
10 mg/day). She was extubated again on POD#4, and 
supplemental oxygen was required for 25 days to keep 
Sa0 2 greater than 90%. She had one episode of rejection, 
which was treated by increasing the baseline FK506 
dose and a steroid volus of Hydrocortisone 300 mg 
intravenously. She was discharged without any oxgen 
therapy 30 days post OLTx. Her oxygenation improved 
showing pao2 of 94 mm Hg on room air 3 months post 
OLTx. 
[Patient3] This nine year old girl was diagnosed 
with alpha-1-antitrypsin deficiency at birth. She had 
a positive history of asthma which was treated with 
ventolin and home nebulization. Physical examination 
revealed remarkable central cyanosis and digital 
clubbing with pao2 of 43 mm Hg. She was mildly 
polycythemic(hematocrit 39.4%). Pulmonary function 
testing was not performed. Her liver function tests 
are shown in Table2. 
She underwent an uneventful OLTx on May 31, 1991. 
She was extubated on POD #1, and started on 
FK506(O.15mg/kg/day intravenous for the first 5 days, 
then 0.3 mg/kg/day orally), and low dose 
steroids(methylprednisolone 10 mg per day). The post 
operative course was uneventful except for one episode 
of mild rejection, which was treated with inreasing 
the baseline FK506 dose and a steroid bolus of 
Hydrocortisone 1 g intravenously. She required oxygen 
supplementation for 14 days. Her oxygenation improved 
showing pao2 of 102 mmHg on room air 5 months post 
OLTx and enjoying such physical activity as 
cheerleading. 
[Patient 4] This 6 year old Arabian boy was diagnosed 
with cryptogenic cirrhosis at the age of 6 months. 
He was referred to our center for possible OLTx. 
Physical examination revealed clubbing but no central 
cyanosis. He complained of mild dyspnea on exertion. 
Echocardiogram demonstrated no evidence of cardiac 
shunting. His arterial blood gas showed mildly decreased 
Pa02 of 74 mmHg. Pulmonary function testing was 
attempted, however adequate cooperation was not 
obtained. His liver function tests are shown in Table2. 
He was not polycythemic with hematocrit of 33.3%. 
He underwent an OLTx on Nov 19,1991. Operation 
and postoperative course were quite uneventful. He 
was put on FK506(0.15 mg/kg /day intravenous for the 
first 5 days, then 0.3 mg/kg/day) and daily 
steroids(methylprednisolone 10 mg/day). He was extubated 
on POD#1 and oxygen supplement was continued for 7 
days. However, two months after surgery he still has 
clubbing of the finger nails, but oxygenation is 
improved showing Pa02 of 89 mmHg on room air. 
Discussion 
Hypoxia is a well known complication in patients 
with ESLD(1-3). It has been recognized that there are 
two categories. One is due to the mechanical 
disturbances of the respiratory system caused by ascites 
and hepatosplenomegaly. In these cases, the hypoxia 
is usually mild. Another group of patients demonstrates 
severe hypoxia with central cyanosis. In 1968, Starzl 
et al described reversal of mild intrapulmonary arterio-
venous shunt in 3 pediatric patients after OLTx(4). 
However, severe hypoxia with Pa02 <SO mmHg has been 
considered a contraindication to OLTx(S,6) because 
hypoxia is most likely secondary to intrapulmonary 
arterio-venous shunting, which is presumably a fixed 
pulmonary vascular abnormality. In fact, a few published 
reports described failed shunt closure post OLTx(S,7-
8). On the other hand, there is one reported reversal 
of hypoxia following OLTx which is that presented by 
Stoller and associates(9). They described an adult 
female with primary biliary cirrhsis whose preoperation 
Pa02 was 60 mmHg and improved to 89 mmHg post OLTx. 
Several physiological mechanisms of pulmonary 
shunting have been proposed including: (A) ventilation 
perfusion mismatch, (B) intrapulmonary or subpleural 
arterio-venous shunting, (C) porto-pulmonary arterio-
venous anastomosis, (D) systemic vein to pulmonary 
vein anastomosis, (E) shift ot the right of 
oxyhemoglobin dissociation curve, and (F) alveolar 
capillary diffusion abnormality(1). Based on 
accumulating evidence, Davis and associates proposed 
intrapulmonary shunting due to abnormal microvascular 
dilatation of the pulmonary circulation as the 
predominant cause of severe hypoxia(10). Their 
hypothesis "Alveolar-Capillary Disequilibrium" implies 
that dilated lung capillaries present long diffusion 
paths for oxygen. As a result, red blood cells moving 
through the center of such vessels cannot receive 
adequate oxygen. They also proposed that vasoactive 
substances similar to those that induce vascular 
spidering in the skin result in pulmonary 
vasodilatation. OLTx presumably eliminates these 
vasoactive substances, thereby reducing the dilated 
capillaries to normal size and improving oxygenation. 
Biliary atresia was the primary disease in 
two of the cases srudied and each had successful 
palliative procedure (Kasai procedure in both cases 
and mesocaval shunt in case 1), which allowed them 
to survive without severe jaundice. Their hypoxic 
presentation appeared later in their course of liver 
disease. 
All patients were extubated POD#1. One required 
re-intubation for atelectasis and bronchoscopy. 
Particular attention was required to keep Sa02 greater 
than 90% for at least 2 weeks post OLTx in order to 
prevent hypoxic damage to the liver. For this reason, 
supplemental oxygen was required for up to 25 days. 
Their oxygenation began to improve 2-3 weeks post OLTx, 
but recovery from hypoxia was not complete until nearly 
3 months post OLTx. They were all discharged from the 
hospital without any oxygen therapy, representing 
dramatically improved oxygenation. 
We reported four pediatric patients with 
pulmonary arterio-venous shunting secondary to ESLD 
which was reversed by successful OLTx. Our experience 
demonstrates OLTx as a valuable therapeutic option 
in normalizing oxygenation in these patients. 
References 
1. Rydell R, Hoffbauer FW. Multiple pulmonary 
arteriovenous fistula in juvenile cirrhosis. Am 
J Med 21: 450, 1 956 . 
2. Silverman AC, Moller JH, Good RA. Syndrome of 
cyanosis, digital clubbing, and hepatic disease 
in siblings. J Pediatric 72: 70, 1968. 
3. Senior ROM, Lefrak SSe The lungs and abdominal 
disease. In Murry JF, Nadel JA ed. Textbook of 
respiratory medicine. Philadelphia, W.B. Saunders 
Company. 1984, 1988. 
4. Starzl TE, Groth CG, Brettschneider L, Moon JB, 
Fulginiti VA, Cotten FK, Porter KA. Extended survival 
in 3 cases of orthotopic homotransplantation of 
the human liver. Surgery 63: 549, 1968. 
-----------------~-~~--
5. Van Thiel DH, Schade RR, Gavaler JS, Shaw BW, 
Iwatsuki S, Starzl TE. Medical aspects of liver 
transplantation. Hepatology 4: 79S, 1984. 
6. Busuttil RW, Goldstein LI, Danovitch GM, Ament ME, 
Memsic LDF. Liver transplantation today. Ann Inter 
Med 1 0 4 : 3 7 7, 1 986 . 
7. Krwoka MJ, Cortese DA. Pulmonary aspect of chronic 
liver disease and transplantation. Mayo Clin Proc 
60: 407, 1985 
8. Krwoka MJ, Cortese DA. Severe hypoxia associated 
with liver disease. Mayo clinic experience and the 
experimental use of almitrine bismesylate. Mayo 
Clin Proc 62: 164, 1987. 
9. Stoller JK, Moodie D, Schiavone WA, Vogt D, Broughan 
T, Winkelman E, Rem PK, Carey WD. Reduction of 
intrapulmonary shunt and resolution of digital 
clubbing associated with primary biliary cirrhosis 
afer liver transplantation. Hematology 11: 54, 1990. 
10.Davis HH, Schwarts DJ, Lefrak SS, Susman N, Schainker 
BA. Alveolar-capillary oxygen disequilibrim in 
hepatic cirrhosis. Chest 73: 507, 1978. 
T
ab
le
 1
 
P
a
ti
e
n
t 
p
ro
fi
le
 
C
as
e 
I 
II
 
II
I 
IV
 
A
ge
 a
t 
O
LT
x 
16
 
7 
9 
6 
(y
ea
rs
) 
S
ex
 
M
 
F 
F 
M
 
P
ri
m
ar
y 
B
il
ia
ry
 
BA
 
A
1A
* 
C
ry
pt
og
en
ic
 
d
is
ea
se
 
a
tr
e
si
a(
B
A
) 
c
ir
rh
o
si
s 
P
re
v
io
u
s 
K
as
ai
 
K
as
ai
 
N
on
e 
N
on
e 
s
u
r
g
er
y
 
M
es
oc
av
al
 s
h
u
n
t 
C
ya
no
si
s 
+
+
 
+
+
 
+
+
 
C
lu
bb
in
g 
+
+
 
+
+
 
+
 
Pa
02
(m
mH
g)
 
o
n
 
ro
o
m
 
a
ir
 
P
re
 
O
LT
x 
56
 
38
 
43
 
74
 
P
o
st
 O
LT
x 
88
(4
) 
94
(3
) 
10
2(
5)
 
89
(2
) 
(m
on
th
s)
 
*
 
A
lp
h
a-
1
-a
n
ti
tr
y
p
si
n
 d
ef
ic
in
cy
 
L
iv
er
 
fu
ct
io
n
 
pr
e-
O
L
T
x 
C
as
e 
I 
II
 
II
I 
IV
 
T
-b
il
ir
u
b
in
 
1
.8
 
1 
.
4
 
2
. 1
 
1 
.
8
 
SG
OT
 
87
 
14
5 
10
9 
96
 
SG
PT
 
49
 
95
 
24
 
59
 
A
lk
al
in
e 
40
8 
71
7 
33
1 
46
7 
p
ho
sp
ha
ta
se
 
G
-G
TP
 
10
9 
35
1 
25
6 
13
9 
PT
 
1
2
.5
 
1 3
.2
 
1
4
.5
 
1
3
.9
 
PT
T 
3
5
.7
 
3
2
.8
 
3
2
.5
 
3
7
.5
 
a
lb
um
in
 
3
.4
 
3
.3
 
3.
 1
 
3
.5
 
N
H
3 
12
8 
10
0 
10
2 
T
ab
le
 
3 
P
ul
m
on
ar
y 
fu
n
ct
io
n
 
te
s
ts
 
(C
as
e 
1)
 
P
re
 
b
ro
n
ch
o
d
il
at
o
r 
P
o
st
 
b
ro
n
ch
o
d
il
at
o
r 
FV
C 
2.
55
 L
 
72
 
%
 
2.
77
 
L 
76
 
%
 
FE
V
 
2.
33
 
L 
75
 
%
 
2
.6
 
L 
84
 
%
 
FE
v/
FV
C
 
91
 
%
 
95
 
%
 
PE
FR
 
4
.2
5
 
L
is
 
75
 
%
 
5.
25
 L
 
93
 
%
 
